Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Merit Medical Systems, Inc. | MMSI | 197.04K | $13.66M |
BioCryst Pharmaceuticals, Inc. | BCRX | 207.36K | $2.07M |
Neurocrine Biosciences, Inc. | NBIX | 213.41K | $35.97M |
Axsome Therapeutics, Inc. | AXSM | 219.6K | $53.75M |
The Cooper Companies, Inc. | COO | 220.89K | $15.84M |
Vera Therapeutics, Inc. | VERA | 224.29K | $9.62M |
Ascendis Pharma A/S | ASND | 233.17K | $62.19M |
Arcutis Biotherapeutics, Inc. | ARQT | 242.07K | $6.35M |
COMPASS Pathways plc | CMPS | 247.59K | $3.5M |
Centene Corp. | CNC | 248.87K | $15.97M |
Definium Therapeutics, Inc. | DFTX | 249.02K | $11.71M |
Edwards Lifesciences Corporation | EW | 250.45K | $22.66M |
BridgeBio Pharma, Inc. | BBIO | 253.36K | $18.87M |
Viking Therapeutics, Inc. | VKTX | 255.33K | $9.96M |
Novo Nordisk A/S | NVO | 265.02K | $12.7M |
Roivant Sciences Ltd. | ROIV | 268.01K | $9.48M |
Inhibrx Biosciences Inc. | INBX | 308.38K | $29.22M |
Tango Therapeutics, Inc. | TNGX | 326.05K | $10.19M |
Celldex Therapeutics, Inc. | CLDX | 342.75K | $12.75M |
Integra LifeSciences Holdings Corporation | IART | 348.75K | $6.26M |